Investor FAQs

Show All
Where can I find Zynerba’s latest investor presentation?
Zynerba’s investor materials are available here.
How do I get news updates from Zynerba?
For news updates, please sign up here.
How do I obtain SEC regulatory filings for Zynerba?
For SEC filings you can sign up for alerts, please sign up here. Alternatively, you can view them on the SEC Filings page.
When is Zynerba’s fiscal year end?
Zynerba’s fiscal year ends on December 31.
When is your next earnings release scheduled? How can I receive email updates for this information?
We will announce our earnings release in due course. For news updates, please sign up here.
When is Zynerba’s Annual Meeting of Stockholders?
The date and location of Zynerba’s Annual Meeting of Stockholders will be published in the company’s proxy statement, which will be announced in due course and can be found on the SEC Filings page.
Whom should I contact regarding investor inquiries?
You can contact for any inquiries or use our contact form here.
Under what exchange do you trade?
Zynerba common stock is traded on NASDAQ under the ticker ZYNE.
When did Zynerba go public? What was the price?
Zynerba began trading on NASDAQ in August of 2015 under the ticker ZYNE. Details of the IPO are available here.
Can I buy stock directly from Zynerba?
No, Zynerba does not have a direct stock purchase plan.
Does Zynerba issue dividends on its common stock?
Zynerba has not paid any dividends to its stockholders since its inception and does not plan to pay any cash dividends in the foreseeable future.
Where is Zynerba located?
Zynerba is located in Devon, PA, a suburb of Philadelphia.

Zynerba Pharmaceuticals
80 W. Lancaster Avenue
Suite 300
Devon, PA 19333
What is Zynerba’s ticker symbol?
Zynerba trades on NASDAQ under the ticker ZYNE.
Who is Zynerba’s transfer agent? How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
For any questions regarding your holdings, please contact our transfer agent:

American Stock Transfer
Operations Center
6201 15th Avenue
Brooklyn, NY 11219
Shareholder Services: 718.921.8124